Ironwood Pharma Inc Class A (IRWD) financials
Ironwood Pharma revenue and earnings by year
Ironwood Pharma's revenue was $296 million in the fiscal year to December 31, 2025, down 15.7% from the year before. Net income was $24.0 million, 8.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 0.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.30 | 0.35 | 0.44 | 0.41 | 0.41 | 0.39 | 0.43 | 0.35 | 0.30 | 0.27 |
| Revenue growth | -15.7% | -20.6% | 7.8% | -0.8% | 6.2% | -9.1% | 23.6% | 16.2% | 8.9% | — |
| Gross profit | — | — | — | — | — | 0.39 | 0.40 | 0.31 | 0.28 | 0.27 |
| Gross margin | — | — | — | — | — | 99.2% | 94.4% | 90.5% | 93.5% | 99.2% |
| Operating income | 0.10 | 0.09 | -0.95 | 0.25 | 0.23 | 0.14 | 0.12 | -0.18 | -0.05 | -0.04 |
| Operating margin | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% | 36.7% | 28.0% | -52.4% | -15.6% | -15.3% |
| Net income | 0.02 | 0.00 | -1.00 | 0.18 | 0.53 | 0.11 | 0.02 | -0.28 | -0.12 | -0.08 |
| Net margin | 8.1% | 0.3% | -226.4% | 42.6% | 127.7% | 27.3% | 5.0% | -81.5% | -39.2% | -29.8% |
| Diluted EPS | $0.13 | -$0.01 | -$6.51 | $0.97 | $3.23 | $0.66 | $0.13 | — | — | — |
| Free cash flow | 0.13 | 0.10 | 0.18 | 0.27 | 0.26 | 0.17 | 0.00 | -0.07 | -0.10 | -0.03 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open IRWD in Markets.
See also: IRWD valuation and P/E history · IRWD returns
No forecast, no recommendation. This page describes Ironwood Pharma Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.